American Kratom Association Praises Secretary Kennedy and Commissioner Makary for Bold Action to Recommend Scheduling of Dangerous 7-OH Products
'Secretary Kennedy and Commissioner Makary have shown exceptional leadership in confronting one of the most urgent public health threats related to mislabeled, manipulated psychoactive substances,' said Mac Haddow, senior fellow on public policy for the American Kratom Association. 'These 7-OH products are not kratom. They are chemically altered substances that carry potent opioid-like effects and pose an imminent threat to consumers. This move sends a clear and long-overdue message: the safety of the American public comes first.'
7-hydroxymitragynine is a metabolite — not a naturally occurring substance in the kratom plant — and occurs during the drying of kratom leaves at extremely low levels, typically less than 0.01%. However, unscrupulous manufacturers have exploited chemical manipulation to create concentrated 7-OH products that far exceed natural levels, creating high-potency, opioid-like effects that are addictive and potentially lethal. These products are often falsely marketed under the kratom name, misleading consumers and damaging the reputation of natural kratom, which has a vastly different safety profile.
The American Kratom Association has worked tirelessly to educate policymakers, regulators, and the public on the difference between natural kratom products and chemically manipulated 7-OH formulations. The AKA has advocated for state-based Kratom Consumer Protection Acts (KCPA) to ban the sale of adulterated and dangerously enhanced products. This federal scheduling recommendation is a landmark development that supports those efforts and establishes a much-needed national framework to protect consumers.
'The FDA's own research shows that natural kratom has a relatively low potential for abuse and may offer harm-reduction benefits when used responsibly,' Haddow continued. 'It is the synthetic manipulation of 7-OH that has created the danger. The action by Secretary Kennedy and Commissioner Makary is not only scientifically justified, it is morally imperative.'
The AKA urges swift action by the Drug Enforcement Administration (DEA) to initiate the rule-making process to schedule synthetically manipulated 7-hydroxymitragynine and to make clear that such action does not impact the legal status of natural kratom or its primary alkaloids, mitragynine and unaltered 7-OH occurring within the plant matrix. The goal is to eliminate the threat posed by rogue products while preserving access to safe, regulated kratom.
'We look forward to working with federal agencies and state policymakers to ensure that safe access to natural kratom is protected, while these dangerous imposters are removed from the marketplace,' said Haddow.
Note: The FDA also released "Hiding in Plain Sight: 7-OH Products, opens new tab" to help educate the public.
About American Kratom Association (AKA)
American Kratom Association (AKA) is a consumer-based, nonprofit organization, focused on furthering the latest science as guidance for kratom public policy. AKA works to give a voice to millions of Americans by fighting to protect their rights to access safe and natural kratom. For more information, visit americankratom.org and learn more at kratomanswers.org.
Media Contact
Mac Haddowpress@americankratom.org
###
SOURCE: American Kratom Association (AKA)
Copyright 2025 EZ Newswire
See release on EZ Newswire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medical News Today
12 hours ago
- Medical News Today
Does Ozempic make you lose muscle?
Ozempic can cause muscle loss along with weight loss. Studies have shown that some people using Ozempic can lose both fat and muscle. If you're concerned with muscle loss while using Ozempic, be sure to talk with your (semaglutide) belongs to a class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1 agonists). Ozempic is approved by the Food and Drug Administration (FDA) for use in people with type 2 diabetes with certain can cause a loss of appetite, which can cause you to lose weight. This includes fat loss, muscle loss, and possibly bone density. Keep reading to learn strategies to help preserve muscle and maintain bone health while using Ozempic is not approved by the FDA for weight loss or weight management. However, some doctors may prescribe the drug off-label for this use. With off-label use, doctors prescribe a drug for a use other than an FDA-approved use. The drug Wegovy contains the same active ingredient as Ozempic, semaglutide, but it comes in higher strengths, and it's approved for weight loss or weight management in certain effects of rapid weight lossThere are concerns about Ozempic's effects on muscle mass and strength. Clinical trials have not specifically linked Ozempic to direct muscle loss. However, some individuals may have a lower appetite, leading to weight loss, which can include loss of both fat and one clinical trial, 86.4% of people taking semaglutide lost 5% or more of their body weight, while 69.1% of people taking the drug lost 10% or have shown that GLP-1 drugs can reduce lean mass, but the results are mixed. (Lean mass can refer to muscle mass, organ size, bone mass, fluids, and water in fat tissue.) For example, semaglutide has been linked to a 40% reduction in lean mass, while liraglutide has been linked to a reduction of up to 60%. (Liraglutide is the active ingredient in the GLP-1 drug Victoza.) Another study comparing semaglutide and tirzepatide with placebo (a drug with no active ingredient) showed a 15% or less decrease in lean mass across all groups. (Tirzepatide is the active ingredient in the GLP-1 drug Zepbound.)Rapid weight loss associated with GLP-1 medications may also affect bone density. A small study showed that people using Victoza had lower bone mineral density in the hip and spine compared to people taking a placebo. However, more studies, especially in different populations, are needed to fully understand the long-term effects of GLP-1 medications on bone weight loss can be beneficial and improve overall health, losing weight rapidly may weaken your musculoskeletal system and cause other health concerns. If you're taking GLP-1 drugs, such as Ozempic, it's important to talk with your doctor about ways to maintain or increase your muscle mass, especially if you experience significant weight muscle loss with OzempicBelow are some strategies that may help prevent muscle loss while using Ozempic:Increase your protein intake: Consuming more protein in your meals can help maintain muscle mass while using Ozempic. This is especially important for older adults and those with other conditions in addition to type 2 diabetes. Diets high in protein can help prevent the loss of lean mass while increasing fat loss. Your doctor or a dietitian can help you determine whether you're getting enough protein in your on strength training: Exercise, especially resistance training, can effectively preserve muscle mass and increase muscle strength and bone density during treatment with GLP-1 drugs. Your doctor can help you determine the right strength training exercises for you. They may also refer you to an exercise therapist if your body composition: To know whether you're maintaining muscle mass with Ozempic, it's important to monitor your body composition with your doctor or another healthcare professional. Body composition measurements can tell you what percentage of fat and muscle you have. Regular assessments can help you and your doctor adjust your diet or exercise plan as needed. Note: Before making changes to your diet or exercise plan, it's important to talk with your doctor to make sure these changes are right for treatments that may help prevent muscle lossA 2025 clinical trial has shown that taking bimagrumab and semaglutide together enhances fat loss and preserves muscle in adults with overweight or obesity. Bimagrumab is a monoclonal antibody drug that has been studied for its effect on promoting fat loss and increasing muscle mass in certain adults with obesity and type 2 is not yet approved for use by the FDA, and it's not approved for use with semaglutide as a combination therapy. But initial research shows the potential of new treatments to help preserve muscle mass in people taking GLP-1 medications like Ozempic is effective for weight loss, it is important to be aware of its potential side effects on muscle and bone health. Strategies such as increasing protein intake, focusing on strength training exercises, and monitoring body composition can help prevent muscle loss while using Ozempic. If you have concerns about losing muscle during Ozempic treatment, be sure to talk with your Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.
Reuters
14 hours ago
- Reuters
US FDA declines to approve Regeneron's blood cancer therapy for second time
Aug 1 (Reuters) - Regeneron (REGN.O), opens new tab said on Friday the U.S. Food and Drug Administration has once again declined to approve its blood cancer therapy, this time in relation to observations from the regulator's inspection at a third-party manufacturing site. The company was seeking approval for its drug odronextamab to treat follicular lymphoma — a type of cancer that begins in the lymph system, a part of the immune system — in patients whose cancer has returned and who have received at least two prior lines of treatment. The regulator had first declined to approve the therapy in March last year, seeking more data from enrollments in dose-finding and confirmatory portions of trials testing it. Regeneron said on Friday the latest FDA decision was due to its inspection at contract manufacturer Catalent's Indiana site, which was acquired by Danish drugmaker Novo Nordisk ( opens new tab. Catalent's Bloomington, Indiana facility is a fill-finish site for Regeneron's Eylea HD and odronextamab, and handles the final stages of drug preparation and packaging. The observations at the inspection have also resulted in delays to three applications for the high-dose version of its eye disease drug Eylea, Regeneron said, adding that Novo has been in communication with the FDA and expects to submit its response next week. There is clear frustration and exhaustion with the repeated regulatory setbacks, said Cantor analyst Carter Gould. Regeneron said the inspection was completed in mid-July and it anticipates an expeditious resolution of the issues. Odronextamab belongs to a class of treatments called bispecific antibodies, which are designed to attach to a cancer cell and an immune cell bringing them together so that the body's immune system can kill the cancer. The drug was approved by the European Commission in August 2024 to treat follicular lymphoma, and is branded as Ordspono in the region.
The Sun
16 hours ago
- The Sun
New 10-question test reveals if your heart is ageing faster than your body – and if you need to take action now
DID you know your heart could age quicker than the rest of your body? Many adults' hearts are up to a decade older than their chronological age, putting them at risk of heart attack, stroke and heart failure, scientists have warned. Calculating your "heart age" doesn't sound particularly doable for most without specialised equipment, but researchers from Northwestern University have put together a free online tool that does just that. Using routine health data such as blood pressure, cholesterol levels and whether you have diabetes or smoke, the 10-question quiz can calculate your heart age based on risk factors for cardiovascular disease (CVD). Being a smoker and having cholesterol, diabetes or high blood pressure can all make heart health issues more likely. Traditionally, heart disease risk is calculated as a percentage. For example, your doctor may say 'eight out of 100 people with your profile may have a heart event in the next 10 years". Researchers wanted to find a less abstract and more relatable way to convey the risk of heart disease. The new online calculator - which used criteria from the American Heart Association - hopes to make heart disease risk easier to understand by reframing it as heart age. Dr Sadiya Khan, the Magerstadt professor of cardiovascular epidemiology at Northwestern University Feinberg School of Medicine, who led the development of the tool, said: 'Many people who should be on medicine to lower their risk for heart attack, stroke or heart failure are not on these medications. 'We hope this tool helps doctors and patients discuss risk for heart disease more effectively so we can better inform what therapies can prevent heart attacks, stroke or heart failure events from ever happening." But researchers stressed that the quiz shouldn't replace medical care and advised people use it in consultation with a doctor. High blood pressure, high cholesterol and type 2 diabetes are all dubbed 'silent killers' - should we really be that worried? Dr Khan and her team put the tool to the test using data from more 14,000 "nationally representative" US adults, aged between 30 to 79. All participants had no prior history of CVD. On average, they found that women had a heart age of 55.4, compared to a chronological age of 51.3. Men had a wider gap, with an average heart age of 56.7 compared to an average chronological age of 49.7. How to reduce your risk of heart attacks and stroke You can reduce your risk of heart attack and stroke with many of the same methods. Heart attacks and strokes, although affecting different organs of the body, are both what we call cardiovascular events. Both arise from similar underlying conditions, such as atherosclerosis —a buildup of fatty deposits in the arteries. According to the American Heart Association, the risk factors for heart attacks and strokes are largely the same: high blood pressure, high cholesterol, smoking, obesity, physical inactivity and diabetes. Therefore, addressing these risk factors can simultaneously reduce the risk of both conditions. Here are ways you can prevent the two: Healthy diet More fruit and veg: The DASH, which emphasises fruit, vegetables, whole grains and lean proteins, has been shown to reduce blood pressure and improve heart health. Less fats: Too much saturated and trans fats can raise cholesterol levels and increase the risk of atherosclerosis. Go for healthier fats like those found in olive oil, nuts, and avocados. Limit salt: High salt intake is linked to high blood pressure, a major risk factor for both heart attack and stroke. The NHS recommends no more than 6g of salt per day for adults. Fibre: Foods high in soluble fibre, such as oats and beans, can help lower cholesterol levels. Exercise Walking, running, cycling, swimming - whatever you like, do it! Aerobic exercise can strengthen the heart and improve circulation. The NHS advises at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of vigorous-intensity activity each week. Strength training exercises can help control weight, improve cholesterol levels, and reduce blood pressure. It is recommended twice a week by the NHS. Manage blood pressure Healthy diet and exercise can help keep your blood pressure in check. But it is worth monitoring it yourself after the age of 40, at least, when the NHS invites adults for a check-up every five years. High blood pressure often has no symptoms but significantly increases the risk of heart attack and stroke. Quit smoking One of the best ways to quit smoking is to use resources provided by NHS Smokefree. Support groups, medications, and other tools to help quit smoking such as vapes could be what you need to kick the habit for good - and it's free. Limit booze Excessive alcohol consumption can increase blood pressure and contribute to weight gain, which can snowball and become a heart health risk. The NHS recommends not regularly drinking more than 14 units of alcohol per week. Nearly a third of men who'd left school at 16 or earlier had a heart age more than 10 years older than their actual age. Black and Hispanic were also more likely to have older hearts. Dr Khan said the heart age calculator could be particularly useful for younger adults who either want to get a head start with protecting their ticker or might need to be on preventative medication. Heart disease is one of the biggest killers worldwide. There are over 7.6 million people living with heart and circulatory diseases in the UK, with numbers projected to rise in the next couple of decades. They cause more than 170,000 deaths a year, according to the British Heart Foundation - that works out to about 480 a day. How to use the tool - and when to be concerned Dr Khan told that the heart age tool can be used as a "forecast" someone's risk of CVD over the next decade. While "it's probably not that meaningful if your age is off by one or two years", she said, the authors recommend getting concerned if the gap is five years or more. If you're seeing a large gap between your heart and actual age, this "likely points to worsening cardiovascular disease risk", even if you're young. 'The important thing is that we have very good options available in our toolbox to help slow that ageing down if we can identify it," Dr Khan noted. "This may be even more important in younger people who don't often think about their risk for heart disease." If your heart age is actually lower than your chronological age - what Dr Khan called the "the Holy Grail" - that's likely thanks to genetics. She suggested using the tool as motivation to boost your heart health, whatever your score. If you're a smoker, quitting the habit is a good place to start, as reducing your consumption of saturated fat if you have high cholesterol, and trying to keep your blood pressure in check. The Northwestern research team now plan to study whether presenting heart disease risk as an age improves outcomes and helps people better understand their need for preventive therapies.
